La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Dignitana Croissance future

Future contrôle des critères 5/6

Dignitana devrait augmenter ses bénéfices et ses revenus de 157.4% et de 40% par an respectivement, tandis que le BPA devrait croître de croître de 170.6% par an.

Informations clés

157.4%

Taux de croissance des bénéfices

170.6%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices	25.4%
Taux de croissance des recettes	40.0%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	17 Nov 2023

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

The Dignitana AB (publ.) (STO:DIGN) Share Price Is Up 123% And Shareholders Are Boasting About It

Dec 10

Prévisions de croissance des bénéfices et des revenus

OM:DIGN - Estimations futures des analystes et données financières antérieures (SEK Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2025	174	21	28	34	1
12/31/2024	120	3	18	23	1
3/31/2024	86	-18	-10	-4	N/A
12/31/2023	86	-17	-10	-6	N/A
9/30/2023	85	-24	-17	-13	N/A
6/30/2023	82	-24	-20	-15	N/A
3/31/2023	79	-20	-23	-19	N/A
12/31/2022	73	-22	-21	-18	N/A
9/30/2022	69	-22	-26	-23	N/A
6/30/2022	64	-33	-35	-29	N/A
3/31/2022	60	-42	-45	-36	N/A
12/31/2021	57	-43	-54	-44	N/A
9/30/2021	54	-52	-51	-38	N/A
6/30/2021	51	-48	-47	-33	N/A
3/31/2021	48	-48	-35	-20	N/A
12/31/2020	47	-53	-42	-21	N/A
9/30/2020	43	-47	-50	-26	N/A
6/30/2020	42	-48	-54	-31	N/A
3/31/2020	43	-45	-57	-31	N/A
12/31/2019	41	-38	-48	-27	N/A
9/30/2019	40	-28	-73	-55	N/A
6/30/2019	40	-24	-64	-47	N/A
3/31/2019	37	-22	-25	-12	N/A
12/31/2018	34	-26	-32	-21	N/A
9/30/2018	31	-34	2	20	N/A
6/30/2018	26	-38	-4	12	N/A
3/31/2018	23	-43	-48	-34	N/A
12/31/2017	23	-43	N/A	-33	N/A
9/30/2017	21	-41	N/A	-45	N/A
6/30/2017	19	-38	N/A	-46	N/A
3/31/2017	14	-34	N/A	-37	N/A
12/31/2016	9	-32	N/A	-31	N/A
9/30/2016	17	-59	N/A	-76	N/A
6/30/2016	15	-56	N/A	-69	N/A
3/31/2016	15	-53	N/A	-68	N/A
12/31/2015	17	-50	N/A	-64	N/A
9/30/2015	14	-12	N/A	-12	N/A
6/30/2015	17	-11	N/A	-3	N/A
3/31/2015	23	-9	N/A	-2	N/A
12/31/2014	21	-11	N/A	-3	N/A
9/30/2014	16	-15	N/A	1	N/A
6/30/2014	13	-16	N/A	-13	N/A
3/31/2014	8	-18	N/A	-17	N/A
12/31/2013	11	-17	N/A	-16	N/A
9/30/2013	6	-17	N/A	-27	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: DIGN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 1.1% ).

Bénéfices vs marché: DIGN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: DIGN devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de DIGN ( 40% par an) devrait croître plus rapidement que le marché Swedish ( 1% par an).

Croissance élevée des revenus: Le chiffre d'affaires de DIGN ( 40% par an) devrait croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de DIGN devrait être élevé dans 3 ans

Dignitana Croissance future

Future contrôle des critères 5/6

Informations clés

Mises à jour récentes de la croissance future

Recent updates

Dignitana AB (publ) to Report Q1, 2025 Results on May 22, 2025

New major risk - Market cap size

Dignitana AB (publ) Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024

New minor risk - Shareholder dilution

Dignitana AB (Publ) Approves the Election of Fredrik Lindgren and Hope S. Rugo as Board Members

Dignitana AB (Publ) Announces Chief Executive Officer Changes , Effective May 2, 2024

Dignitana AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 19.128698 million.

Dignicap Delta Study Underway in Brindisi, Italy

Dignitana AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 19.128698 million.

Full year 2023 earnings: EPS and revenues miss analyst expectations

Dignitana Announces DigniCap Delta Receives Market Approval in Japan

Dignitana Announces Preliminary Results of DigniCap Delta Study Demonstrates 79% Efficacy

Third quarter 2023 earnings released: kr0.052 loss per share (vs kr0.056 loss in 3Q 2022)

Dignitana AB (publ) to Report Fiscal Year 2023 Final Results on May 02, 2024

Dignitana AB (publ), Annual General Meeting, May 23, 2024

Dignitana (STO:DIGN) Is Carrying A Fair Bit Of Debt

Dignitana AB Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy

Dignitana AB Long-Term Study Demonstrates Safety and Efficacy of Scalp Cooling to Reduce Chemo Hair Loss

Second quarter 2023 earnings released: kr0.066 loss per share (vs kr0.004 loss in 2Q 2022)

New minor risk - Share price stability

We Think Dignitana (STO:DIGN) Has A Fair Chunk Of Debt

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2022 earnings: EPS and revenues miss analyst expectations

Dignitana AB (publ) to Report Fiscal Year 2022 Final Results on May 04, 2023

Third quarter 2022 earnings released: kr0.056 loss per share (vs kr0.21 loss in 3Q 2021)

Dignitana AB Appoints Nomination Committee

Dignitana AB (publ) Hires Johan Johansson to Head Operations, Research and Development

Less than half of directors are independent

Dignitana AB (publ) Launches DigniCap Direct Partner Portal

Second quarter 2022 earnings released: kr0.004 loss per share (vs kr0.15 loss in 2Q 2021)

We Think Dignitana (STO:DIGN) Has A Fair Chunk Of Debt

Dignitana AB (publ) to Report Q1, 2023 Results on May 25, 2023

Now 26% undervalued after recent price drop

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Dignitana AB (publ) Appoints Ulf Jönsson as Chief Financial Officer

Should You Investigate Dignitana AB (publ) (STO:DIGN) At kr6.04?

Now 24% undervalued after recent price drop

Less than half of directors are independent

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Dignitana AB (publ.) (STO:DIGN) Is Carrying A Fair Bit Of Debt

Full year 2021 earnings: EPS and revenues miss analyst expectations

Dignitana AB (publ.) Appoints Alf Christensson as Interim CFO, Effective March 1, 2022

Dignitana Appoints Catarina Mård Löwenadler as CEO

Third quarter 2021 earnings released: kr0.21 loss per share (vs kr0.18 loss in 3Q 2020)

Dignitana AB (publ.) (STO:DIGN) Has Debt But No Earnings; Should You Worry?

Second quarter 2021 earnings released: kr0.15 loss per share (vs kr0.17 loss in 2Q 2020)

Dignitana AB Launches New Initiatives to Support Reimbursement and Market Access

Independent Director has left the company

Independent Director has left the company

First quarter 2021 earnings released: kr0.12 loss per share (vs kr0.23 loss in 1Q 2020)

New 90-day low: kr7.84

Full year 2020 earnings released: kr0.96 loss per share (vs kr0.76 loss in FY 2019)

Dignitana AB (publ.) (STO:DIGN) Has Debt But No Earnings; Should You Worry?

New 90-day high: kr8.94

Dignitana AB Announces Highly Recognized Mammazentrum Hamburg Is Upgrading Their Existing Scalp Cooling Program to the Next Generation Dignicap Delta System

The Dignitana AB (publ.) (STO:DIGN) Share Price Is Up 123% And Shareholders Are Boasting About It

GenesisCare selects Dignitana as Preferred Scalp Cooling Provider for its Rapidly Expanding Australia Medical Oncology Centres

Dignitana AB (publ.) to Report Q3, 2021 Results on Nov 18, 2021

Cancer Leader City of Hope Selects Dignitana AB (Publ.) for Community Network in California

Dignitana AB Announces Agreement with ION Solutions

New 90-day high - kr8.06

Earnings released

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance